A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
Clinical trial NCT05297045 · TERMINATED
Trial details
- NCT number
- NCT05297045
- Sponsor
- Regor Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2023-05-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.